{"public_id":"cl_64cc7f9e3a60c207e4ffd3126ff57b29","status":"active","superseded_by_public_id":null,"corpus_id":11671167,"text":"ABCB1 is identified as a genetic factor associated with resistance to antiepileptic drugs.","confidence":0.88,"paper":{"corpus_id":11671167,"title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.","url":"https://sah.borca.ai/papers/11671167"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.88,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_2c5f1b3384f43008e391be03588185fd","name":"ABCB1","description":"A drug-transporter gene that encodes P-glycoprotein 170 and is also known as MDR1.","types":["gene"],"url":"https://sah.borca.ai/concepts/co_2c5f1b3384f43008e391be03588185fd"},{"public_id":"co_c9d56cd7bad34cd0a6781b66963021b4","name":"drug-resistant epilepsy","description":"Epilepsy that remains resistant to multiple antiepileptic drugs.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_c9d56cd7bad34cd0a6781b66963021b4"},{"public_id":"co_cf9d73f3890780a265bee343a67305e0","name":"antiepileptic drug resistance","description":"Reduced effectiveness of antiepileptic medications in controlling seizures.","types":["clinical outcome"],"url":"https://sah.borca.ai/concepts/co_cf9d73f3890780a265bee343a67305e0"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_64cc7f9e3a60c207e4ffd3126ff57b29"}